KALA BIO is a clinical-stage biopharmaceutical company on a mission. Guided by advanced science and an ever-climbing optimism, we’re focused on solving rare and serious eye diseases through research and development of innovative therapies. KALA BIO is a leader in the emerging field of mesenchymal stem cell secretome (MSC-S) therapy. Using our proprietary MSC-S platform, we are developing therapies with regenerative healing effects for rare ocular surface and retinal diseases, with the ultimate goal of preserving vision and changing lives.
Data Provided by Refinitiv. Minimum 15 minutes delayed.